Anti-cytokine heterocyclic compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S491000

Reexamination Certificate

active

08063094

ABSTRACT:
Heterocyclic compounds which are inhibitors of Mitrogen-Activated Protein Kinase-Activated Protein Kinase-2 (MAPKAP-K2) as described, in addition to their use in the treatment of cytokine mediated diseases.

REFERENCES:
patent: 3216898 (1965-11-01), Fellows
patent: 4428877 (1984-01-01), Szantay et al.
patent: 4839377 (1989-06-01), Bays et al.
patent: 6821966 (2004-11-01), Dugar et al.
patent: 6906067 (2005-06-01), Moriarty et al.
patent: 7169925 (2007-01-01), Merriman et al.
patent: 2006/0183906 (2006-08-01), Rodgers et al.
patent: 2006/0276496 (2006-12-01), Goldberg et al.
patent: 888.426 (1958-04-01), None
Bradham et al, p38 MAPK in Development and Cancer, Cell Cycle, 2006, vol. 5:8, p. 824-828.
Evgen'ev et al, Flow-Injection Determination of Indole Derivatives in Pharmaceutical Mixtures, Journal of Analytical Chemistry, 2006, vol. 6, No. 7, p. 694-701.
Golub et al, Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring, Science, 1999, vol. 286, p. 531-537.
King, Role of Inflammatory Cytokines in Diabetes and Its Complications, J. Periodontol, Jun. 2008, vol. 79, p. 1527-1534.
Medical News: Inflammatory Cytokines Linked to Alzheimers Disease, http://www.medpagetoday.com/Neurology/AlzheimersDisease/5796, accessed Apr. 26, 2011.
Moya et al, Synthesis of 7-fluoro- and 6,7-difluoroserotonin and 7-fluoro- and 6,7-difluoromelatonin, Journal of Fluorine Chemistry, 2006, vol. 127, p. 1256-1260.
Shioi et al, Proinflammatory Cytokine Inhibitor Prolongs Survival of Rats with Heart Failure Induced by Pressure Overload, Jpn Circ J, 2001, vol. 65, p. 584-585.
Targeted Cancer Therapies, http://www.cancer.gov/cancertopics/factsheet/therapy/targeted, accessed Jan. 12, 2011.
Zenvirt et al, Status of p53 in human cancer cells does not predict efficacy of CHK1 kinase inhibitors combined with chemotherapeutic agents, Oncogene, 2010, vol. 29, p. 6149-6159.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Anti-cytokine heterocyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-cytokine heterocyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-cytokine heterocyclic compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4277621

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.